Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Jfrog Ltd (FROG) is a leading software-application business based in the US. It opened the day at $21.13 after a previous close of $21.07. During the day the price has varied from a low of $21.01 to a high of $22.05. The latest price was $21.94 (25 minute delay). Jfrog Ltd is listed on the NASDAQ and employs 1,000 staff. All prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Open | $21.13 |
|---|---|
| High | $22.05 |
| Low | $21.01 |
| Close | $21.94 |
| Previous close | $21.07 |
| Change | $0.87 |
| Change % | 4.1291% |
| Volume | 680,964 |
| 52-week range | $16.36 - $48.55 |
|---|---|
| 50-day moving average | $19.85 |
| 200-day moving average | $26.94 |
| Wall St. target price | $27.17 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.79 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $21.94 from 2022-06-30
| 1 week (2022-06-24) | -5.31% |
|---|---|
| 1 month (2022-05-29) | N/A |
| 3 months (2022-03-29) | -16.39% |
| 6 months (2021-12-31) | -26.13% |
| 1 year (2021-07-02) | -52.36% |
|---|---|
| 2 years (2020-06-28) | N/A |
| 3 years (2019-06-28) | N/A |
| 5 years (2017-06-28) | N/A |
| Revenue TTM | $225.3 million |
|---|---|
| Gross profit TTM | $164.9 million |
| Return on assets TTM | -5.09% |
| Return on equity TTM | -12.71% |
| Profit margin | -33.74% |
| Book value | $6.45 |
| Market capitalisation | $2.2 billion |
TTM: trailing 12 months
We're not expecting Jfrog Ltd to pay a dividend over the next 12 months.
JFrog Ltd. provides DevOps platform in the United States. The company's products include JFrog Artifactory, a package repository that allows teams and organizations to store, update, and manage their software packages at any scale; JFrog Pipelines, an integration/continuous delivery tool for automating and orchestrating the movement of software packages; JFrog Xray, which scan JFrog Artifactory; and JFrog Distribution that provides software package distribution with enterprise-grade performance. Its products include JFrog Artifactory Edge that utilizes and leverages metadata from JFrog Artifactory to facilitate the transfer of the incremental changes in software packages from their previous versions; JFrog Mission Control, a platform control panel that provides a view of moving pieces of an organization's software supply chain workflow; JFrog Insight, a DevOps intelligence tool; and JFrog Connect, a device management solution that allows companies to manage software updates and monitor performance across IoT device fleets from anywhere in the world. The company's products also comprise JFrog Pro, JFrog Pro Team, JFrog Pro X, JFrog Enterprise, JFrog Enterprise X, and JFrog Enterprise Plus products that offer ongoing updates, upgrades, and bug fixes, as well as cluster configuration, multi-site replication, and SLA support. It serves technology, financial services, retail, healthcare, and telecommunications organizations. JFrog Ltd.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
